Traphaco plans higher revenue and profit in 2023

Traphaco PharmaceuticWorkers checking products at Traphaco Pharmaceutical Joint Stock Company (TRA). TRA plans to achieve revenue of VNĐ2.6 trillion (US$110.9 million) and profit after tax of VNĐ326 billion in 2023, up 8.4 per cent and 11.2. per cent, respectively compared to the previous year. Photo Traphaco